Anemia and CKD: What Your Blood Count Means and What to Ask

Anemia is a condition in which the blood carries less oxygen than usual. It can happen because the body has fewer red blood cells than normal, or because the red blood cells contain less hemoglobin, the protein that carries oxygen. Either way, the tissues receive less oxygen, which is why common symptoms include fatigue, weakness, low energy, paleness, and shortness of breath on effort.

Anemia is not a single disease. It is a finding on a blood test that has many possible causes, and in CKD the most common cause is different from the most common cause in the general population. In people with healthy kidneys, iron deficiency is the most common cause by far. In people with CKD, reduced production of the hormone erythropoietin is a major additional cause, and iron deficiency and inflammation often contribute as well.

The key point for people with CKD: anemia is common, detectable by a simple blood test, and often treatable. Treating it is not the same as curing kidney disease, but it can improve energy and quality of life for many people.

In the United States, roughly one in five to four in ten adults with moderate to advanced CKD has anemia, and the share rises as kidney function falls. In people on dialysis, most have a hemoglobin below the normal range at some point. Yet anemia remains under-recognized, partly because it develops gradually.

The kidneys do more than filter blood. They also produce erythropoietin, a hormone that tells the bone marrow to make red blood cells. As chronic kidney disease progresses, the kidneys produce less erythropoietin, and the bone marrow makes fewer red blood cells. This is the main reason anemia becomes more common as kidney function declines.

Several other factors add to the problem in CKD:

• Iron deficiency. CKD can cause iron loss through bleeding in the gut, blood loss during dialysis, reduced iron absorption, and upregulation of hepcidin, a liver hormone that blocks iron release from storage.

• Inflammation. Chronic inflammation or persistent illness raises hepcidin further and can make the bone marrow less responsive to erythropoietin.

• Blood loss. Dialysis treatment itself can cause some blood loss; repeated small losses can add up.

• Other causes. Vitamin B12 and folate deficiency, blood disorders unrelated to kidney disease, and effects of some medicines can also contribute.

This means a person with CKD and anemia often has more than one reason for it. That is why the evaluation usually checks iron status and sometimes other causes, not only hemoglobin.

Diagnosis starts with a blood test. The most common one is a complete blood count (CBC), which reports hemoglobin, hematocrit, red blood cell count, and other values. Hemoglobin is the number most clinicians use to decide whether anemia is present and how severe it is.

The second group of tests looks at iron status. These usually include ferritin, which reflects iron stores, and transferrin saturation (TSAT), which reflects iron available for making red blood cells. Low ferritin or low TSAT suggests iron deficiency, but values can be misleading with chronic inflammation, so the interpretation belongs to your care team.

Sometimes more tests are needed, such as measuring vitamin B12, folate, or the reticulocyte count, which shows whether the bone marrow is responding. In most routine CKD care, the CBC plus iron tests are enough to start.

One practical note: the same blood count can look different depending on hydration, blood thinning, or recent bleeding, and values from different laboratories can differ slightly. That is why trends over time matter as much as any single result, and why your care team will usually compare the current value with previous ones before acting.

Hemoglobin

Normal hemoglobin is usually around 12 to 15.5 g/dL (or 120 to 155 g/L) in adult women and around 13.5 to 17.5 g/dL (135 to 175 g/L) in adult men, with variation by laboratory, age, and other factors. In CKD, anemia is typically defined at thresholds below those ranges, and a drop from your own previous value matters too.

Ferritin and transferrin saturation

Two iron measures matter most in CKD. Ferritin reflects how much iron is stored; levels below roughly 100 ng/mL may suggest depletion, although inflammation can raise ferritin and mask true deficiency. Transferrin saturation (TSAT) reflects iron that is currently available for red blood cell production; values below about 20% often suggest functional iron deficiency, while higher values can indicate iron overload. Read both together with your clinician, because neither alone tells the whole story.

Some guidelines routinely recommend checking iron stores before starting anemia treatment and again after several weeks of iron therapy, because the response to treatment is partly driven by iron availability.

Why one number is not the whole story

A single hemoglobin value does not answer the question by itself. Your own baseline, the rate of change, iron results, kidney function, symptoms, and the presence of bleeding or inflammation all shape the meaning. For example, a mild drop over many months may matter differently than a fast drop in a few weeks. Your care team interprets the pattern, not just the number.

What your care team will do next

If anemia is confirmed, the next steps usually include checking iron status, reviewing medicines and other causes, and deciding whether treatment is needed. Treatment may involve iron replacement, an erythropoiesis-stimulating agent (ESA), or sometimes both.

Iron replacement

If iron is low, replacing it is often the first step. Iron can be given by mouth or, in some cases, by intravenous infusion, especially when oral iron is not tolerated or not effective. A common practical note: some oral iron products are better absorbed when taken on an empty stomach, but some people get stomach upset, so absorption practicalities come with trade-offs.

Erythropoiesis-stimulating agents (ESAs)

ESAs are medicines that act like erythropoietin and prompt the bone marrow to make red blood cells. They are given by injection, often under the skin, and are usually reserved for people with moderate to severe anemia or those whose anemia does not respond to iron, or people on dialysis. They are not for everyone.

Important: ESA treatment has risks. It can raise the risk of blood clots, high blood pressure, and, in some studies, cardiovascular events when hemoglobin is pushed too high. Guidelines therefore recommend specific upper targets, commonly avoiding hemoglobin above about 11 to 11.5 g/dL. The decision to use an ESA, the dose, and the target are individual medical decisions.

Because of these risks, guidelines are clear that ESAs should not be used to push hemoglobin above the recommended range, and that the lowest dose that keeps a person out of severe anemia is the goal. Asking about your own goal, what the dose depends on, and what you should watch for is part of a good conversation with your care team.

Other medicines and transfusions

Some people may also need vitamin B12 or folate if those are low. In an acute emergency, blood transfusions can quickly improve oxygen delivery, though they are a short-term measure rather than a long-term treatment. Newer medicines that act on the hypoxia-inducible factor (HIF) pathway are also approved in some regions, and their place is discussed with your care team.

Anemia is one of those topics that is easy to miss in a busy clinic visit, because the symptoms build slowly and people often blame tiredness on other things. Bringing a recent lab report and asking one clear question can change how quickly the issue is addressed.

Signs that warrant a call or visit

Contact your care team if you have new or worsening fatigue that interferes with daily activities, unexplained weakness, breathlessness on light activity, or significant paleness. Also call if you have signs of bleeding, such as black or tarry stools, blood in the stool, or persistent unusual bruising, or if you have been told that your blood counts are dropping.

What to ask at your next visit

• What is my recent hemoglobin, and what was it before?

• What are my iron results, and do I need iron replacement?

• If I need treatment, what are the benefits, risks, and targets?

• How often will my blood counts be checked?

• What symptoms should make me call or visit early?